About

A Body Shape Index (ABSI) isolates the mortality risk attributable to abdominal adiposity after adjusting for body size. Standard BMI conflates lean mass with fat mass and ignores fat distribution entirely. ABSI corrects this by normalizing waist circumference (WC) against BMI^2/3 and height^1/2, producing a dimensionless index. The metric was derived by Krakauer & Krakauer (2012) from NHANES III and NHANES 1999-2004 cohorts comprising over 14,000 adults. A higher ABSI z-score correlates with increased hazard ratios for all-cause premature mortality independent of BMI. Failing to account for waist-specific risk means two individuals with identical BMI of 25 kg/m² may face vastly different cardiovascular outcomes.

This calculator computes ABSI, its population-referenced z-score, and an approximate relative mortality risk category. The reference means and standard deviations are stratified by sex and age (years 2 - 85) from published NHANES-derived tables. Limitations: the model assumes a US population distribution. Ethnic-specific recalibration data remain limited. Measurement error in WC of even 2 cm shifts the z-score meaningfully. Always measure waist circumference at the iliac crest on bare skin during exhalation.

Formulas

The A Body Shape Index is computed by removing the allometric scaling of waist circumference with respect to BMI and height:

ABSI = WCBMI^2/3 ⋅ H^1/2

where WC = waist circumference in m, BMI = body mass index in kg/m², and H = height in m.

BMI itself is the standard Quetelet index:

BMI = WH²

where W = body weight in kg.

The population-standardized z-score transforms ABSI into a relative risk measure:

ABSI_z = ABSI − ABSI_meanABSI_sd

where ABSI_mean and ABSI_sd are age- and sex-specific population reference values derived from NHANES data. The z-score maps to mortality risk quintiles: Q1 (z < −0.868) through Q5 (z > 0.798), with relative hazard ratios ranging from 0.76 to 1.61.

Reference Data

ABSI z-score Range	Risk Quintile	Relative Mortality Risk	Interpretation
< −0.868	Q1 (Very Low)	0.76	Substantially below-average abdominal risk
−0.868 to −0.272	Q2 (Low)	0.89	Below-average abdominal risk
−0.272 to 0.229	Q3 (Average)	1.00	Population-average risk (reference)
0.229 to 0.798	Q4 (High)	1.13	Above-average abdominal risk
> 0.798	Q5 (Very High)	1.61	Substantially elevated mortality hazard
Reference BMI & WC Benchmarks
Underweight	BMI < 18.5 kg/m²		Low body mass, ABSI may be artificially elevated
Normal weight	18.5 ≤ BMI < 25		ABSI most clinically meaningful in this range
Overweight	25 ≤ BMI < 30		Moderate adiposity; WC adds prognostic value
Obese Class I	30 ≤ BMI < 35		High risk; ABSI captures visceral fat component
Obese Class II	35 ≤ BMI < 40		Very high risk baseline
Obese Class III	BMI ≥ 40		Extreme risk; comorbidity screening essential
Male WC threshold	> 102 cm		ATP III elevated risk cutoff
Female WC threshold	> 88 cm		ATP III elevated risk cutoff
WHO Male WC (action level 1)	≥ 94 cm		Increased metabolic risk
WHO Female WC (action level 1)	≥ 80 cm		Increased metabolic risk
WHO Male WC (action level 2)	≥ 102 cm		Substantially increased risk
WHO Female WC (action level 2)	≥ 88 cm		Substantially increased risk
Du Bois BSA constant	0.007184		Empirical coefficient for body surface area
Height exponent (BSA)	0.725		Du Bois formula power for height in cm
Weight exponent (BSA)	0.425		Du Bois formula power for weight in kg

Frequently Asked Questions

BMI measures total mass relative to height squared and cannot distinguish visceral fat from muscle or subcutaneous fat. Two individuals with identical BMI values can have radically different abdominal fat deposits. ABSI isolates the waist circumference component that is not already explained by BMI and height, capturing the independent contribution of central adiposity to mortality risk. In the Krakauer study, ABSI was a significant predictor of hazard ratio even after full adjustment for BMI, age, and sex.

The NHANES protocol specifies measurement at the superior border of the iliac crest (top of the hip bone). The tape must be horizontal, snug but not compressing the skin, and the reading taken at the end of a normal exhalation. Measuring at the navel or narrowest point introduces systematic bias that shifts the ABSI z-score. A measurement error of just 2 cm can move the z-score by approximately 0.3 to 0.5 standard deviations depending on body size.

The population-average ABSI (ABSImean) increases with age due to natural redistribution of fat toward the trunk. ABSImean for a 25-year-old male is approximately 0.0790 m^(11/6)/kg^(2/3), while for a 70-year-old male it is approximately 0.0834. Without age-sex stratification, a 70-year-old with a normal-for-age waist would be falsely flagged as high risk. The standard deviation (ABSIsd) also varies, so both parameters are required for accurate z-score computation.

The original derivation cohort had limited representation at the extremes of BMI. For underweight individuals (BMI below 18.5), the BMI^(2/3) denominator becomes small, which can artificially inflate ABSI. For BMI above 40, the allometric scaling assumption (that WC scales as BMI^(2/3)) may break down because extremely high adiposity changes body geometry nonlinearly. Use results in these ranges as directional estimates rather than precise risk classifications.

The reference tables used in this calculator cover ages 2 through 85. However, for children under age 18, the z-score references are less robust because pediatric body composition changes rapidly during growth spurts. The Krakauer mortality hazard ratios were derived exclusively from adults aged 18 and older. For pediatric patients, the z-score still indicates relative body shape compared to age peers, but the mortality risk interpretation does not directly apply.

The NHANES reference population is predominantly a US demographic mix. Asian populations tend to accumulate visceral fat at lower BMI thresholds, meaning their ABSI z-scores may underestimate true abdominal risk. Conversely, some African-descent populations carry more subcutaneous rather than visceral abdominal fat, potentially overestimating risk. Ethnic-specific recalibration studies exist but are not yet incorporated into standardized reference tables. Interpret cross-ethnic comparisons with caution.

For clinical monitoring, recalculate every 3 to 6 months alongside weight and waist circumference measurements. Short-term fluctuations (days to weeks) reflect water retention and meal timing more than genuine fat redistribution. A sustained change in ABSI z-score of more than 0.5 over 6 months is clinically meaningful and warrants further cardiovascular risk assessment. Consistency in measurement technique (same time of day, same clothing state, same anatomical landmark) is critical for longitudinal tracking.